Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
R3H domain containing 2 pseudogene 2 (abbreviated R3HDM2P2) is classified as a human pseudogene. Pseudogenes are DNA sequences that resemble genes but are non-functional due to mutations or deletions and do not encode functional proteins. R3HDM2P2 shares homology with the protein-coding gene R3HDM2, which contains an R3H domain associated with nucleic acid binding, but there is no evidence that R3HDM2P2 is transcribed into a functional protein or has biological activity. It is not considered a therapeutic target, has no known biological functions, disease associations, or drug interactions, and serves a mainly genomic annotation role rather than a functional or therapeutic one.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on R3H domain containing 2 pseudogene 2 (R3HDM2P2).